Pricing Log in Create free account

ANIXA BIOSCIENCES INC (ANIX) vs Rani Therapeutics Holdings, Inc. (RANI)

ANIXA BIOSCIENCES INC and Rani Therapeutics Holdings, Inc. are both Biotechnology companies. ANIXA BIOSCIENCES INC and Rani Therapeutics Holdings, Inc. are of similar size ($96.7M and $94.8M). Rani Therapeutics Holdings, Inc. grew revenue faster over the last twelve months: 78.7% against −34.1%. ANIXA BIOSCIENCES INC has the higher net margin (0.00% vs −597.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, ANIXA BIOSCIENCES INC leads on 9 and Rani Therapeutics Holdings, Inc. on 6.

Valuation

Metric ANIX RANI Biotechnology median
P/E n/m n/m 8.50
P/S 93.90 23.73 9.71
P/B 6.91 2.50 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 83.50 16.27 9.21
Earnings yield (11.99%) (42.19%) (33.15%)
Free cash flow yield (8.04%) (16.98%) (25.50%)

Profitability

Metric ANIX RANI Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (652.78%) 0.00%
Net margin 0.00% (596.97%) 0.00%
Free cash flow margin 0.00% (402.83%) 0.00%
Return on equity (72.57%) (155.24%) (56.36%)
Return on assets (63.45%) (77.54%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ANIX RANI Biotechnology median
Revenue growth (TTM) (34.10%) 78.73% 6.02%
EPS growth (last fiscal year) 12.82% 57.14% 30.26%
Revenue growth, 5-year CAGR (6.89%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ANIX RANI Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 8.55 5.31 4.72
Net debt to EBITDA 1.29 1.33 0.96

Dividend

Metric ANIX RANI Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ANIX RANI Biotechnology median
Market cap 96.65m 94.79m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack